• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

木葡聚糖嵌段聚(ε-己内酯)共聚物纳米粒子,壳聚糖涂层,作为生物相容的黏附性药物传递系统。

Xyloglucan-block-poly(ϵ-caprolactone) copolymer nanoparticles coated with chitosan as biocompatible mucoadhesive drug delivery system.

机构信息

Departamento de Ciências Farmacêuticas, Centro de Ciências da Saúde, Universidade Federal de Santa Catarina (UFSC), Campus Universitário Trindade, 88040-900, Florianópolis, SC, Brazil.

出版信息

Macromol Biosci. 2014 May;14(5):709-19. doi: 10.1002/mabi.201300465. Epub 2014 Jan 28.

DOI:10.1002/mabi.201300465
PMID:24469965
Abstract

The development of novel xyloglucan-block-poly(ϵ-caprolactone) (XGO-b-PCL) nanoparticles coated with the mucoadhesive polysaccharide chitosan is described. XGO-b-PCL nanoparticles show monodisperse size distribution (Rh  = 50 nm). Curcumin is successfully encapsulated within the PCL core within drug to polymer ratio of 1:5 (w/w). The coating of nanoparticles with chitosan results in an increased particle size and positive surface charge due to the polycation nature of the chitosan. Mucoadhesive properties of chitosan-coated nanoparticles are demonstrated by its exceptional ability to interact with mucin through electrostatic forces. Finally, in vitro studies show that curcumin-loaded nanoparticles exhibit higher cytotoxic effects against B16F10 melanoma cells than L929 fibroblast cells.

摘要

新型木葡聚糖-block-聚(ε-己内酯)(XGO-b-PCL)纳米粒子的开发,该纳米粒子用粘多糖壳聚糖进行了涂层修饰。XGO-b-PCL 纳米粒子显示出单分散的粒径分布(Rh=50nm)。姜黄素在药物与聚合物比例为 1:5(w/w)的情况下成功地被包裹在 PCL 核内。由于壳聚糖的聚阳离子性质,纳米粒子的涂层导致粒径增加和表面带正电荷。壳聚糖涂层纳米粒子的粘弹性通过其与粘蛋白的静电相互作用的特殊能力得到证明。最后,体外研究表明,负载姜黄素的纳米粒子对 B16F10 黑色素瘤细胞的细胞毒性作用高于 L929 成纤维细胞。

相似文献

1
Xyloglucan-block-poly(ϵ-caprolactone) copolymer nanoparticles coated with chitosan as biocompatible mucoadhesive drug delivery system.木葡聚糖嵌段聚(ε-己内酯)共聚物纳米粒子,壳聚糖涂层,作为生物相容的黏附性药物传递系统。
Macromol Biosci. 2014 May;14(5):709-19. doi: 10.1002/mabi.201300465. Epub 2014 Jan 28.
2
Elaboration of chitosan-coated nanoparticles loaded with curcumin for mucoadhesive applications.壳聚糖载姜黄素纳米粒的制备及其黏附性能研究。
J Colloid Interface Sci. 2012 Mar 15;370(1):58-66. doi: 10.1016/j.jcis.2011.12.063. Epub 2012 Jan 8.
3
Mucoadhesive films containing chitosan-coated nanoparticles: a new strategy for buccal curcumin release.含有壳聚糖包被纳米颗粒的粘膜粘附膜:一种用于口腔姜黄素释放的新策略。
J Pharm Sci. 2014 Nov;103(11):3764-3771. doi: 10.1002/jps.24142. Epub 2014 Sep 3.
4
Intravesical cationic nanoparticles of chitosan and polycaprolactone for the delivery of Mitomycin C to bladder tumors.用于将丝裂霉素C递送至膀胱肿瘤的壳聚糖和聚己内酯膀胱内阳离子纳米颗粒。
Int J Pharm. 2009 Apr 17;371(1-2):170-6. doi: 10.1016/j.ijpharm.2008.12.015. Epub 2008 Dec 24.
5
A novel biocompatible drug delivery system of chitosan/temozolomide nanoparticles loaded PCL-PU nanofibers for sustained delivery of temozolomide.一种新型的生物相容性药物递送系统,壳聚糖/替莫唑胺纳米颗粒负载聚己内酯-聚氨酯纳米纤维用于替莫唑胺的持续递送。
Int J Biol Macromol. 2017 Apr;97:744-751. doi: 10.1016/j.ijbiomac.2017.01.073. Epub 2017 Jan 18.
6
Curcumin-containing chitosan nanoparticles as a potential mucoadhesive delivery system to the colon.载姜黄素壳聚糖纳米粒作为一种潜在的结肠黏附给药系统。
Pharm Dev Technol. 2013 May-Jun;18(3):591-9. doi: 10.3109/10837450.2011.640688. Epub 2011 Dec 10.
7
On the mucoadhesive properties of chitosan-coated polycaprolactone nanoparticles loaded with curcumin using quartz crystal microbalance with dissipation monitoring.采用石英晶体微天平耗散监测法研究载姜黄素壳聚糖包覆聚己内酯纳米粒的黏膜黏附性能。
J Biomed Nanotechnol. 2014 May;10(5):787-94. doi: 10.1166/jbn.2014.1768.
8
Curcumin delivery by methoxy polyethylene glycol-poly(caprolactone) nanoparticles inhibits the growth of C6 glioma cells.甲氧基聚乙二醇-聚己内酯纳米粒递送姜黄素抑制 C6 神经胶质瘤细胞生长。
Acta Biochim Biophys Sin (Shanghai). 2011 Apr;43(4):267-74. doi: 10.1093/abbs/gmr011. Epub 2011 Feb 24.
9
Galactosylated chitosan-polycaprolactone nanoparticles for hepatocyte-targeted delivery of curcumin.半乳糖化壳聚糖-聚己内酯纳米粒用于姜黄素的肝细胞靶向递送。
Carbohydr Polym. 2013 Apr 15;94(1):420-9. doi: 10.1016/j.carbpol.2013.01.014. Epub 2013 Jan 16.
10
Poly(ethyleneglycol)-b-poly(ε-caprolactone-co-γ-hydroxyl-ε- caprolactone) bearing pendant hydroxyl groups as nanocarriers for doxorubicin delivery.具有侧挂羟基的聚(乙二醇)-b-聚(ε-己内酯-co-γ-羟基-ε-己内酯)作为阿霉素递送的纳米载体。
Biomacromolecules. 2012 Oct 8;13(10):3301-10. doi: 10.1021/bm301086c. Epub 2012 Sep 14.

引用本文的文献

1
Development of modular polymeric nanoparticles for drug delivery using amine reactive chemistry.采用胺反应化学制备用于药物传递的模块化聚合物纳米粒子。
J Pharm Pharm Sci. 2024 Aug 6;27:13148. doi: 10.3389/jpps.2024.13148. eCollection 2024.
2
Enzyme-Triggered Intestine-Specific Targeting Adhesive Platform for Universal Oral Drug Delivery.酶触发的肠道特异性靶向黏附平台用于通用口服药物递送。
Adv Healthc Mater. 2023 Oct;12(27):e2301033. doi: 10.1002/adhm.202301033. Epub 2023 Jun 30.
3
Advances in Chitosan-based Drug Delivery Systems in Melanoma: A Narrative Review.
基于壳聚糖的黑色素瘤药物递送系统的研究进展:一项叙述性综述。
Curr Med Chem. 2024;31(23):3488-3501. doi: 10.2174/0929867330666230518143654.
4
Biodegradable Nanoparticles Loaded with Levodopa and Curcumin for Treatment of Parkinson's Disease.载有左旋多巴和姜黄素的可生物降解纳米粒子治疗帕金森病。
Molecules. 2022 Apr 28;27(9):2811. doi: 10.3390/molecules27092811.
5
Novel Curcumin-Resveratrol Solid Nanoparticles Synergistically Inhibit Proliferation of Melanoma Cells.新型姜黄素-白藜芦醇固体纳米颗粒协同抑制黑色素瘤细胞增殖。
Pharm Res. 2021 May;38(5):851-871. doi: 10.1007/s11095-021-03043-7. Epub 2021 May 12.
6
Curcumin Delivery Mediated by Bio-Based Nanoparticles: A Review.基于生物的纳米粒子介导的姜黄素传递:综述。
Molecules. 2020 Feb 6;25(3):689. doi: 10.3390/molecules25030689.
7
Fluorescence properties of curcumin-loaded nanoparticles for cell tracking.载姜黄素纳米粒子的荧光性质及其用于细胞示踪。
Int J Nanomedicine. 2018 Sep 28;13:5823-5836. doi: 10.2147/IJN.S171099. eCollection 2018.
8
The potential of chitosan and its derivatives in prevention and treatment of age-related diseases.壳聚糖及其衍生物在预防和治疗与年龄相关疾病方面的潜力。
Mar Drugs. 2015 Apr 13;13(4):2158-82. doi: 10.3390/md13042158.